Clinical Trial Update: Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating reduced-dose radiotherapy versus standard-dose radiotherapy for early-stage nasopharyngeal carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Hai-Qiang Mai,MD,PhD | Conditions: Nasopharyngeal Cancinoma (NPC) | Phase 3 | Status: RECRUITING